{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T15:13:13Z","timestamp":1785683593256,"version":"3.56.0"},"reference-count":130,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T00:00:00Z","timestamp":1714780800000},"content-version":"am","delay-in-days":338,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgpath.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Pathology Clinics"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.path.2023.01.009","type":"journal-article","created":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T15:37:32Z","timestamp":1678462652000},"page":"361-383","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Aggressive Cutaneous Lymphomas and Their Mimics"],"prefix":"10.1016","volume":"16","author":[{"given":"Andrea P.","family":"Moy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa P.","family":"Pulitzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.path.2023.01.009_bib1","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissue","first-page":"202","article-title":"Primary cutaneous diffuse large B-cell lymphoma","author":"Willemze","year":"2017"},{"issue":"9","key":"10.1016\/j.path.2023.01.009_bib2","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1001\/archderm.143.9.1144","article-title":"Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases","volume":"143","author":"Grange","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.path.2023.01.009_bib3","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1111\/j.1468-3083.2006.02073.x","article-title":"Primary cutaneous large B-cell lymphoma, leg type, presented with a migratory lesion","volume":"21","author":"Ekmekci","year":"2007","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.path.2023.01.009_bib4","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.jaad.2015.02.1134","article-title":"Atypical clinicopathologic presentation of primary cutaneous diffuse large B-cell lymphoma, leg type","volume":"72","author":"Massone","year":"2015","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.path.2023.01.009_bib5","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1182\/blood-2012-10-460063","article-title":"MYC\/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-SHOP Consortium Program","volume":"121","author":"Hu","year":"2013","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.path.2023.01.009_bib6","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/DAD.0b013e3181eeb433","article-title":"The histomorphologic spectrum of primary cutaneous diffuse large B-cell lymphoma: a study of 79 cases","volume":"33","author":"Plaza","year":"2011","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.path.2023.01.009_bib7","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1046\/j.1365-2133.2000.03471.x","article-title":"Primary cutaneous B-cell lymphoma: a clinical, histopathological, phenotypic and genotypic study of 21 cases","volume":"142","author":"Gronbaeck","year":"2000","journal-title":"Br J Dermatol"},{"issue":"7","key":"10.1016\/j.path.2023.01.009_bib8","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1182\/blood-2005-03-1175","article-title":"Primary cutaneous large B-cell lymphomas: clinicopathologic features, classification, and prognostic factors in a large series of patients","volume":"106","author":"Kodama","year":"2005","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.path.2023.01.009_bib9","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1200\/JCO.2006.09.6396","article-title":"Reclassification of 300 primary cutaneous B-cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers","volume":"25","author":"Senff","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.path.2023.01.009_bib10","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/j.1365-2133.2003.05649.x","article-title":"Bcl-2, Bcl-6 and CD10 expression in cutaneous B-cell lymphoma: further support for a follicle centre cell origin and differential diagnostic significance","volume":"149","author":"Hoefnagel","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.path.2023.01.009_bib11","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1034\/j.1600-0560.2002.290310.x","article-title":"Primary cutaneous CD30 (Ki-1)-positive non-anaplastic B-cell lymphoma","volume":"29","author":"Herrera","year":"2002","journal-title":"J\u00a0Cutan Pathol"},{"issue":"1","key":"10.1016\/j.path.2023.01.009_bib12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/01.pai.0000143347.58174.91","article-title":"Primary cutaneous CD30+ large cell B-cell lymphoma: a series of 10 cases","volume":"14","author":"Magro","year":"2006","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.path.2023.01.009_bib13","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1182\/blood-2012-10-461848","article-title":"CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study","volume":"121","author":"Hu","year":"2013","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.path.2023.01.009_bib14","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1365-2133.2012.10987.x","article-title":"Expression of the T-cell regulatory marker FOXP3 in primary cutaneous large B-cell lymphoma tumour cells","volume":"167","author":"Felcht","year":"2012","journal-title":"Br J Dermatol"},{"issue":"8","key":"10.1016\/j.path.2023.01.009_bib15","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1038\/jid.2012.102","article-title":"MYD88 somatic mutation is a genetic feature of primary cutaneous diffuse large B-cell lymphoma, leg type","volume":"132","author":"Pham-Ledard","year":"2012","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.path.2023.01.009_bib16","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/j.jid.2016.04.018","article-title":"MYD88 somatic mutation is a diagnostic criterion in primary cutaneous large B-cell lymphoma","volume":"136","author":"Menguy","year":"2016","journal-title":"J\u00a0Invest Dermatol"},{"issue":"1","key":"10.1016\/j.path.2023.01.009_bib17","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/jid.2013.265","article-title":"Nuclear factor-\u03baB pathway-activating gene aberrancies in primary cutaneous large B-cell lymphoma, leg type","volume":"134","author":"Koens","year":"2014","journal-title":"J\u00a0Invest Dermatol"},{"issue":"9","key":"10.1016\/j.path.2023.01.009_bib18","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1016\/j.jid.2017.04.010","article-title":"Identification of somatic mutations in primary cutaneous diffuse large B-cell lymphoma, leg type by massive parallel sequencing","volume":"137","author":"Mareschal","year":"2017","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.path.2023.01.009_bib19","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1016\/j.jid.2018.04.038","article-title":"Genomic analyses identify recurrent alterations in immune evasion genes in diffuse large B-cell lymphoma, leg type","volume":"138","author":"Zhou","year":"2018","journal-title":"J\u00a0Invest Dermatol"},{"issue":"12","key":"10.1016\/j.path.2023.01.009_bib20","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1600-0625.2005.00376.x","article-title":"Comparative genomic hybridization analysis of cutaneous large B-cell lymphomas","volume":"14","author":"Gimenez","year":"2005","journal-title":"Exp Dermatol"},{"issue":"2","key":"10.1016\/j.path.2023.01.009_bib21","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1200\/JCO.2005.02.0842","article-title":"Array-based comparative genomic hybridization analysis reveals recurrent chromosomal alterations and prognostic parameters in primary cutaneous large B-cell lymphoma","volume":"24","author":"Dijkman","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.path.2023.01.009_bib22","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/jid.2008.357","article-title":"Fine-mapping chromosomal loss at 9p21: correlation with prognosis in primary cutaneous diffuse large B-cell lymphoma, leg type","volume":"129","author":"Senff","year":"2009","journal-title":"J\u00a0Invest Dermatol"},{"issue":"5","key":"10.1016\/j.path.2023.01.009_bib23","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1038\/jid.2009.418","article-title":"IRF4 expression without IRF4 rearrangement is a general feature of primary cutaneous diffuse large B-cell lymphoma, leg type","volume":"130","author":"Pham-Ledard","year":"2010","journal-title":"J\u00a0Invest Dermatol"},{"issue":"2","key":"10.1016\/j.path.2023.01.009_bib24","first-page":"213","article-title":"FOXP1 molecular cytogenetics and protein expression analyses in primary cutaneous large B cell lymphoma, leg-type","volume":"26","author":"Espinet","year":"2011","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.path.2023.01.009_bib25","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/modpathol.2013.156","article-title":"Multiple genetic alterations in primary cutaneous large B-cell lymphoma, leg type support a common lymphomagenesis with activated B-cell-like diffuse large B-cell lymphoma","volume":"27","author":"Pham-Ledard","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.path.2023.01.009_bib26","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1097\/PAS.0000000000001132","article-title":"High incidence and clinical significance of MYC rearrangements in primary cutaneous diffuse large B-cell lymphoma, leg type","volume":"42","author":"Schrader","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2023.01.009_bib27","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1038\/s41379-018-0041-7","article-title":"Double-hit or dual expression of MYC and BCL2 in primary cutaneous large B-cell lymphomas","volume":"31","author":"Menguy","year":"2018","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1016\/j.path.2023.01.009_bib28","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1111\/j.1365-2133.2007.08239.x","volume":"157","author":"Senff","year":"2007","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.path.2023.01.009_bib29","doi-asserted-by":"crossref","first-page":"521","DOI":"10.2340\/00015555-1112","article-title":"Survival data for 299 patients with primary cutaneous lymphomas: a monocentre study","volume":"91","author":"Hallermann","year":"2011","journal-title":"Acta Derm Venereol"},{"issue":"5","key":"10.1016\/j.path.2023.01.009_bib30","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1111\/j.1365-2133.2012.11122.x","article-title":"Primary cutaneous B-cell lymphoma in Nottinghamshire U.K.: prognosis of subtypes defined in the WHO-EORTC classification","volume":"167","author":"Bessell","year":"2012","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.path.2023.01.009_bib31","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1001\/jamadermatol.2013.7452","article-title":"Improvement of survival in patients with primary cutaneous diffuse large B-cell lymphoma, leg type, in France","volume":"150","author":"Grange","year":"2014","journal-title":"JAMA Dermatol"},{"issue":"4","key":"10.1016\/j.path.2023.01.009_bib32","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1046\/j.1365-2133.2001.04128.x","article-title":"Absence of the t(14;18) chromosomal translocation in primary cutaneous B-cell lymphoma","volume":"144","author":"Child","year":"2001","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.path.2023.01.009_bib33","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1182\/bloodadvances.2020002469","article-title":"Genomic landscape of cutaneous follicular lymphomas reveals 2 subgroups with clinically predictive molecular features","volume":"5","author":"Zhou","year":"2021","journal-title":"Blood Adv"},{"issue":"9","key":"10.1016\/j.path.2023.01.009_bib34","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1182\/blood-2004-04-1594","article-title":"Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profiling","volume":"105","author":"Hoefnagel","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.path.2023.01.009_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.153804","article-title":"Immunohistochemical algorithms and gene expression profiling in primary cutaneous B-cell lymphoma","volume":"231","author":"Cretella","year":"2022","journal-title":"Pathol Res Pract"},{"issue":"3","key":"10.1016\/j.path.2023.01.009_bib36","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00428-021-03265-5","article-title":"Cell-of-origin classification using the Hans and Lymph2Cx algorithms in primary cutaneous large B-cell lymphomas","volume":"480","author":"Schrader","year":"2022","journal-title":"Virchows Arch"},{"issue":"4","key":"10.1016\/j.path.2023.01.009_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0266978","article-title":"Integrative diagnosis of primary cutaneous large B-cell lymphomas supports the relevance of cell of origin profiling","volume":"17","author":"Gros","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.path.2023.01.009_bib38","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/cup.13382","article-title":"Cutaneous localization of angioimmunoblastic T-cell lymphoma may masquerade as B-cell lymphoma or classical Hodgkin lymphoma: a histologic diagnostic pitfall","volume":"46","author":"Szablewski","year":"2019","journal-title":"J\u00a0Cutan Pathol"},{"issue":"6","key":"10.1016\/j.path.2023.01.009_bib39","doi-asserted-by":"crossref","first-page":"789","DOI":"10.5021\/ad.2016.28.6.789","article-title":"A\u00a0case of cutaneous Epstein-Barr virus-associated diffuse large B-cell lymphoma in an angioimmunoblastic T-cell lymphoma","volume":"28","author":"Lee","year":"2016","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.path.2023.01.009_bib40","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1746-1596-7-7","article-title":"Secondary cutaneous Epstein-Barr virus-associated diffuse large B-cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma: a case report and review of the literature","volume":"7","author":"Yang","year":"2012","journal-title":"Diagn Pathol"},{"issue":"12","key":"10.1016\/j.path.2023.01.009_bib41","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1097\/DAD.0000000000001371","article-title":"Epstein\u2013Barr virus\u2013induced cutaneous diffuse large B-cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma","volume":"41","author":"Poon","year":"2019","journal-title":"Am J Dermatopathol"},{"issue":"3","key":"10.1016\/j.path.2023.01.009_bib42","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1365-2230.2010.03934.x","article-title":"Cutaneous features of intravascular lymphoma","volume":"36","author":"Wahie","year":"2011","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"10.1016\/j.path.2023.01.009_bib43","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1159\/000228328","article-title":"Intravascular large B-cell lymphoma of the skin: typical clinical manifestations and a favourable response to rituximab-containing therapy","volume":"219","author":"Feldmann","year":"2009","journal-title":"Dermatology"},{"key":"10.1016\/j.path.2023.01.009_bib44","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/bjh.16081","article-title":"Diagnosis of intravascular large B-cell lymphoma: novel insights into clinicopathologic features from 42 patients at a single institution over 20 years","volume":"187","author":"Matsue","year":"2019","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.path.2023.01.009_bib45","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.jaad.2019.09.015","article-title":"Skin biopsy in the diagnosis of intravascular lymphoma: a retrospective diagnostic accuracy study","volume":"85","author":"Rozenbaum","year":"2021","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.path.2023.01.009_bib46","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1159\/000079597","article-title":"Intravascular large B-cell lymphoma colonizing cutaneous hemangiomas","volume":"209","author":"Cerroni","year":"2004","journal-title":"Dermatology"},{"key":"10.1016\/j.path.2023.01.009_bib47","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1182\/blood-2017-12-822817","article-title":"High prevalence of MYD88 and CD79B mutations in intravascular large B-cell lymphoma","volume":"131","author":"Schrader","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.path.2023.01.009_bib48","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/bjd.15841","article-title":"Molecular classification of tumour cells in a patient with intravascular large B-cell lymphoma","volume":"178","author":"Bauer","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.path.2023.01.009_bib49","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1365-2559.2005.01985.x","article-title":"Plasmablastic lymphoma arising at a cutaneous site","volume":"46","author":"Jordan","year":"2005","journal-title":"Histopathology"},{"issue":"7","key":"10.1016\/j.path.2023.01.009_bib50","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.path.2023.01.009_bib51","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The international consensus classification of mature lymphoid neoplasms: a report from the Clinical Advisory Committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.path.2023.01.009_bib52","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1046\/j.1365-2133.2003.05544.x","article-title":"Post-transplant plasmablastic lymphoma of the skin","volume":"149","author":"Nicol","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.path.2023.01.009_bib53","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.0303-6987.2004.00197.x","article-title":"Post-transplant lymphoproliferative disorder limited to the skin","volume":"31","author":"Samolitis","year":"2004","journal-title":"J\u00a0Cutan Pathol"},{"issue":"6","key":"10.1016\/j.path.2023.01.009_bib54","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1600-0560.2009.01449.x","article-title":"Cutaneous presentation of post-renal transplant lymphoproliferative disorder: a series of four cases","volume":"37","author":"Salama","year":"2010","journal-title":"J\u00a0Cutan Pathol"},{"issue":"8","key":"10.1016\/j.path.2023.01.009_bib55","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1111\/ajt.12281","article-title":"Primary cutaneous posttransplant lymphoproliferative disorders in solid organ transplant recipients: a multicenter European case series","volume":"13","author":"Se\u00e7kin","year":"2013","journal-title":"Am J Transplant"},{"issue":"7","key":"10.1016\/j.path.2023.01.009_bib56","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1097\/PAS.0000000000000225","article-title":"Methotrexate-associated B-cell lymphoproliferative disorders presenting in the skin: a clinicopathologic and immunophenotypical study of 10 cases","volume":"38","author":"Koens","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2023.01.009_bib57","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1097\/PAS.0b013e31822067d1","article-title":"Nonhepatosplenic \u03b3\/\u03b4 T-cell lymphomas represent a spectrum of aggressive cytotoxic T-cell lymphomas with a mainly extranodal presentation","volume":"35","author":"Garcia-Herrera","year":"2011","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.path.2023.01.009_bib58","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/PAS.0b013e318275d1a2","article-title":"TCR-\u03b3 expression in primary cutaneous T-cell lymphomas","volume":"37","author":"Rodriguez-Pinilla","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2023.01.009_bib59","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1001\/jamadermatol.2018.1264","article-title":"Hematophagocytic lymphohistiocytosis in cutaneous T-cell lymphoma","volume":"154","author":"Lee","year":"2018","journal-title":"JAMA Dermatology"},{"key":"10.1016\/j.path.2023.01.009_bib60","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1097\/PAS.0b013e31826a5038","article-title":"Cutaneous gamma\/delta T-cell lymphomas. A spectrum of presentations with overlap with other cytotoxic lymphomas","volume":"36","author":"Guitart","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2023.01.009_bib61","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1097\/PAS.0000000000000295","article-title":"Cytotoxic T-cell and NK-cell lymphomas: current questions and controversies","volume":"38","author":"Swerdlow","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"10.1016\/j.path.2023.01.009_bib62","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nrclinonc.2009.169","article-title":"Gamma-delta T-cell lymphomas","volume":"6","author":"Tripodo","year":"2009","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.path.2023.01.009_bib63","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1111\/cup.12830","article-title":"Gamma\/delta T-cell in cutaneous and subcutaneous lymphoid infiltrates: malignant or not?","volume":"43","author":"Guitart","year":"2016","journal-title":"J\u00a0Cutan Pathol"},{"key":"10.1016\/j.path.2023.01.009_bib64","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/PCR.0000000000000047","article-title":"Primary cutaneous gamma-delta T-cell lymphoma positive for both T-cell receptor gamma and T-cell receptor beta","volume":"19","author":"Omland","year":"2014","journal-title":"Pathol Case Rev"},{"key":"10.1016\/j.path.2023.01.009_bib65","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/jdv.12477","article-title":"Silent T-cell lymphoma of gamma\/delta T-cell origin initially presented as panniculitis","volume":"29","author":"Patsatsi","year":"2015","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.path.2023.01.009_bib66","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/PAS.0000000000000786","article-title":"Immunophenotypic shifts in primary cutaneous gamma\/delta T-cell lymphoma suggest antigentic modulation: a study of sequential biopsy specimens","volume":"41","author":"Agbay","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.path.2023.01.009_bib67","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1111\/cup.14063","article-title":"Gamma\/delta T-cell lymphoma with mycosis fungoides-like clinical course transforming to \"T-cell-receptor-silent\" aggressive lymphoma: description of one case","volume":"48","author":"Tomasini","year":"2021","journal-title":"J\u00a0Cutan Pathol"},{"key":"10.1016\/j.path.2023.01.009_bib68","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1038\/ncomms7025","article-title":"Activating mutations of STAT5B and STAT3 in lymphomas derived from \u03b3\u03b4-T or NK cells","volume":"6","author":"Kucuk","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.path.2023.01.009_bib69","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1038\/s41467-020-15572-7","article-title":"Cellular origins and genetic landscape of cutaneous gamma delta T cell lymphomas","volume":"11","author":"Daniels","year":"2020","journal-title":"Nat Commun"},{"issue":"9","key":"10.1016\/j.path.2023.01.009_bib70","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1182\/blood-2002-05-1597","article-title":"Gamma-delta T-cell phenotype is associated with significantly decreased survival in cutaneous T-cell lymphoma","volume":"101","author":"Toro","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.path.2023.01.009_bib71","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/PAS.0000000000000768","article-title":"Primary cutaneous T-cell lymphomas showing gamma-delta phenotype and predominnalty epidermotropic pattern are clinicopathologically distinct from classic primary cutaneous gamma\/delta T-cell lymphomas","volume":"41","author":"Merrill","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"10.1016\/j.path.2023.01.009_bib72","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/DAD.0000000000000029","article-title":"Two cases of primary cutaneous lymphoma with a \u03b3\/\u03b4+ phenotype and an indolent course","volume":"36","author":"Kempf","year":"2014","journal-title":"Am J Dermatopathol"},{"issue":"12","key":"10.1016\/j.path.2023.01.009_bib73","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1111\/cup.14082","article-title":"The significance of epidermal involvement in primary cutaneous gamma\/delta (\u03b3\u03b4) T-cell lymphoma: a systematic review and meta-analysis","volume":"48","author":"Goyal","year":"2021","journal-title":"J\u00a0Cutan Pathol"},{"issue":"2","key":"10.1016\/j.path.2023.01.009_bib74","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/bjd.13364","article-title":"\u03b3\u03b4 T-cell-rich variants of pityriasis lichenoides and lymphomatoid papulosis: benign cutaneous disorders to be distinguished from aggressive cutaneous \u03b3\u03b4 T-cell lymphomas","volume":"172","author":"Martinez-Escala","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.path.2023.01.009_bib75","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1097\/DAD.0000000000001352","article-title":"A\u00a0reactive peripheral gamma-detla T-cell lymphoid proliferation after a tick bite","volume":"41","author":"Martin","year":"2019","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.path.2023.01.009_bib76","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/his.13671","article-title":"T-cell receptor-\u03b4 expression and \u03b3\/\u03b4+ T-cell infiltrates in primary cutaneous \u03b3\u03b4 T-cell lymphoma and other cutaneous T-cell lymphoproliferative disorders","volume":"73","author":"Pulitzer","year":"2018","journal-title":"Histopathology"},{"issue":"2","key":"10.1016\/j.path.2023.01.009_bib77","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/PAS.0000000000000307","article-title":"Lobular panniculitic infiltrates with overlapping histopathologic features of lupus panniculitis (lupus profundus) and subcutaneous T-cell lymphoma: a conceptual and practical dilemma","volume":"39","author":"Bosisio","year":"2015","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.path.2023.01.009_bib78","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/j.1365-2133.2008.08761.x","article-title":"The prognosis of early mycosis fungoides is not influenced by phenotype and T-cell clonality","volume":"159","author":"Massone","year":"2008","journal-title":"Br J Dermatol"},{"issue":"11","key":"10.1016\/j.path.2023.01.009_bib79","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/j.1600-0560.2007.00931.x","article-title":"Transformation of cutaneous gamma\/delta T-cell lymphoma following 15 years of indolent behavior","volume":"35","author":"Hosler","year":"2008","journal-title":"J\u00a0Cutan Pathol"},{"issue":"10","key":"10.1016\/j.path.2023.01.009_bib80","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1097\/DAD.0b013e318289c9b8","article-title":"Rapid progression of primary cutaneous gamma-delta T-cell lymphoma with an initial indolent clinical presentation","volume":"36","author":"Alexander","year":"2014","journal-title":"Am J Dermatopathol"},{"issue":"5","key":"10.1016\/j.path.2023.01.009_bib81","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.jaad.2020.10.012","article-title":"Diagnosis of gamma\/delta mycosis fungoides requires longitudinal clinical observation","volume":"85","author":"Ferrier","year":"2021","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.path.2023.01.009_bib82","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jdermsci.2017.08.012","article-title":"Differential expression of CCR4 in primary cutaneous gamma\/delta (\u03b3\u2044\u03b4) T cell lymphomas and mycosis fungoides: significance for diagnosis and therapy","volume":"89","author":"Jour","year":"2018","journal-title":"J\u00a0Dermatol Sci"},{"issue":"2","key":"10.1016\/j.path.2023.01.009_bib83","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/his.13960","article-title":"C-C chemokine receptor 4 expression in CD8+ cutaneous T-cell lymphomas and lymphoproliferative disorders, and its implications for diagnosis and treatment","volume":"76","author":"Geller","year":"2020","journal-title":"Histopathology"},{"issue":"3","key":"10.1016\/j.path.2023.01.009_bib84","doi-asserted-by":"crossref","first-page":"702","DOI":"10.3324\/haematol.2020.274506","article-title":"Deregulation of JAK2 signaling underlies primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphoma","volume":"107","author":"Bastidas Torres","year":"2022","journal-title":"Haematologica"},{"issue":"23","key":"10.1016\/j.path.2023.01.009_bib85","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1182\/blood.2021012536","article-title":"Primary cytotoxic T-cell lymphomas harbor recurrent targetable alterations in the JAK-STAT pathway","volume":"138","author":"Lee","year":"2021","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.path.2023.01.009_bib86","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/j.1600-0560.2011.01741.x","article-title":"Relapsed hepatosplenic T-cell lymphoma heralded by a solitary skin nodule","volume":"38","author":"Hocker","year":"2011","journal-title":"J\u00a0Cutan Pathol"},{"issue":"5","key":"10.1016\/j.path.2023.01.009_bib87","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/DAD.0000000000001569","article-title":"A\u00a0skin plaque preceding systemic relapse of gamma-delta hepatosplenic T-cell lymphoma","volume":"42","author":"Santonja","year":"2020","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.path.2023.01.009_bib88","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s00428-016-2006-x","article-title":"Cutaneous presentation of hepatosplenic T-cell lymphoma: a potential mimicker of primary cutaneous gamma-delta T-cell lymphoma","volume":"469","author":"Karpate","year":"2016","journal-title":"Virchows Arch"},{"issue":"1","key":"10.1016\/j.path.2023.01.009_bib89","doi-asserted-by":"crossref","first-page":"30","DOI":"10.12788\/j.sder.2018.015","article-title":"NK\/T-cell lymphoma, nasal type, \u03b3\u03b4 T-cell lymphoma, and CD8-positive epidermotropic T-cell lymphoma-clinical and histopathologic features, differential diagnosis, and treatment","volume":"37","author":"Geller","year":"2018","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.path.2023.01.009_bib90","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/modpathol.2016.240","article-title":"Primary cutaneous aggressive epidermotropic cytotoxic T-cell lymphomas: reappraisal of a provisional entity in the 2016 WHO classification of cutaneous lymphomas","volume":"30","author":"Guitart","year":"2017","journal-title":"Mod Pathol"},{"issue":"12","key":"10.1016\/j.path.2023.01.009_bib91","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/gcc.22673","article-title":"Array-based CGH of primary cutaneous CD8+ aggressive EPIDERMO-tropic cytotoxic T-cell lymphoma","volume":"57","author":"Fanoni","year":"2018","journal-title":"Genes Chromosomes Cancer"},{"issue":"4","key":"10.1016\/j.path.2023.01.009_bib92","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/his.12371","article-title":"Aggressive epidermotropic cutaneous CD8+ lymphoma: a cutaneous lymphoma with distinct clinical and pathological features. Report of an EORTC Cutaneous Lymphoma Task Force Workshop","volume":"67","author":"Robson","year":"2015","journal-title":"Histopathology"},{"key":"10.1016\/j.path.2023.01.009_bib93","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0002-9440(10)65144-9","article-title":"Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behaviour","volume":"155","author":"Berti","year":"1999","journal-title":"Am J Pathol"},{"issue":"5","key":"10.1016\/j.path.2023.01.009_bib94","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/modpathol.3880088","article-title":"Pagetoid reticulosis (Woringer-Kolopp disease): an immunophenotypic, molecular, and clinicopathologic study","volume":"13","author":"Haghighi","year":"2000","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1016\/j.path.2023.01.009_bib95","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1600-0560.2009.01323.x","article-title":"CD4\/CD8 double negative pagetoid reticulosis: a case report and literature review","volume":"37","author":"Mourtzinos","year":"2010","journal-title":"J\u00a0Cutan Pathol"},{"issue":"2","key":"10.1016\/j.path.2023.01.009_bib96","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/DAD.0b013e318297f7fd","article-title":"Indolent CD8+ lymphoid proliferation of the face with eyelid involvement","volume":"36","author":"Hagen","year":"2014","journal-title":"Am J Dermatopathol"},{"issue":"9","key":"10.1016\/j.path.2023.01.009_bib97","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1600-0560.2009.01448.x","article-title":"Indolent CD8-positive lymphoid proliferation on the face: part of the spectrum of primary cutaneous small-\/medium-sized pleomorphic T-cell lymphoma or a distinct entity?","volume":"37","author":"Suchak","year":"2010","journal-title":"J\u00a0Cutan Pathol"},{"issue":"2","key":"10.1016\/j.path.2023.01.009_bib98","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/DAD.0b013e31825c3a33","article-title":"Primary cutaneous CD8(+) small- to medium-sized lymphoproliferative disorder in extrafacial sites: clinicopathologic features and concept on their classification","volume":"35","author":"Kempf","year":"2013","journal-title":"Am J Dermatopathol"},{"issue":"2","key":"10.1016\/j.path.2023.01.009_bib99","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/cup.12045","article-title":"Indolent CD8(+) lymphoid proliferation of acral sites: a clinicopathologic study of six patients with some atypical features","volume":"40","author":"Greenblatt","year":"2013","journal-title":"J\u00a0Cutan Pathol"},{"issue":"4","key":"10.1016\/j.path.2023.01.009_bib100","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/DAD.0b013e3182a74c7a","article-title":"Multicenter case series of indolent small\/medium-sized CD8+ lymphoid proliferations with predilection for the ear and face","volume":"36","author":"Li","year":"2014","journal-title":"Am J Dermatopathol"},{"issue":"5","key":"10.1016\/j.path.2023.01.009_bib101","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1600-0560.2010.01526.x","article-title":"Non-mycosis fungoides cutaneous T-cell lymphoma: reclassification according to the WHO-EORTC classification","volume":"37","author":"Weaver","year":"2010","journal-title":"J\u00a0Cutan Pathol"},{"issue":"1","key":"10.1016\/j.path.2023.01.009_bib102","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/PAS.0000000000000312","article-title":"Primary cutaneous NK\/T-cell lymphoma, nasal type and CD56-positive peripheral T-cell lymphoma: a cellular lineage and clinicopathologic study of 60 patients from Asia","volume":"39","author":"Takata","year":"2015","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.path.2023.01.009_bib103","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/PAS.0b013e31824433d8","article-title":"Extranodal NK\/T-cell lymphoma, nasal type, includes cases of natural killer cell and \u03b1\u03b2, \u03b3\u03b4, and \u03b1\u03b2\/\u03b3\u03b4 T-cell origin: a comprehensive clinicopathologic and phenotypic study","volume":"36","author":"Pongpruttipan","year":"2012","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.path.2023.01.009_bib104","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1053\/j.semdp.2019.12.004","article-title":"Epstein-Barr virus positive T and NK-cell lymphoproliferations: morphological features and differential diagnosis","volume":"37","author":"Montes-Mojarro","year":"2020","journal-title":"Semin Diagn Pathol"},{"issue":"8","key":"10.1016\/j.path.2023.01.009_bib105","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1200\/JCO.2001.19.8.2179","article-title":"Natural killer\/natural killer-like T-cell lymphoma, CD56+, presenting in the skin: an increasingly recognized entity with an aggressive course","volume":"19","author":"Mraz-Gernhard","year":"2001","journal-title":"J\u00a0Clin Oncol"},{"issue":"10","key":"10.1016\/j.path.2023.01.009_bib106","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1093\/annonc\/mds096","article-title":"Extranodal natural killer\/T-cell lymphoma from skin or soft tissue: suggestion of treatment from multinational retrospective analysis","volume":"23","author":"Ahn","year":"2012","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.path.2023.01.009_bib107","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.humpath.2008.08.020","article-title":"Extranodal nasal-type natural killer\/T-cell lymphoma of the skin: a clinicopathologic study of 16 cases in China","volume":"40","author":"Yu","year":"2009","journal-title":"Hum Pathol"},{"issue":"7","key":"10.1016\/j.path.2023.01.009_bib108","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1093\/annonc\/mdh268","article-title":"CD56+ hematological neoplasms presenting in the skin: a retrospective analysis of 23 new cases and 130 cases from the literature","volume":"15","author":"Bekkenk","year":"2004","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.path.2023.01.009_bib109","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1093\/annonc\/mdp418","article-title":"NK-cell Tumor Study Group. Prognostic factors for mature natural killer (NK) cell neoplasms: aggressive NK cell leukemia and extranodal NK cell lymphoma, nasal type","volume":"21","author":"Suzuki","year":"2010","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.path.2023.01.009_bib110","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1309\/MN4Y8HLQWKD9NB5E","article-title":"EBV viral load in tumor tissue is an important prognostic indicator for nasal NK\/T-cell lymphoma","volume":"128","author":"Hsieh","year":"2007","journal-title":"Am J Clin Pathol"},{"issue":"12","key":"10.1016\/j.path.2023.01.009_bib111","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/pin.12346","article-title":"Methotrexate-associated lymphoproliferative disorder presenting as extranodal NK\/T-cell lymphoma arising in the lungs","volume":"65","author":"Tajima","year":"2015","journal-title":"Pathol Int"},{"issue":"1","key":"10.1016\/j.path.2023.01.009_bib112","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/00129039-200203000-00002","article-title":"Hydroa-like cutaneous T-cell lymphoma: a clinicopathologic and molecular genetic study of 16 pediatric cases from Peru","volume":"10","author":"Barrionuevo","year":"2002","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"2","key":"10.1016\/j.path.2023.01.009_bib113","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jaad.2014.10.006","article-title":"Cutaneous manifestations of human T-cell lymphotrophic virus type-1-associated adult T-cell leukemia\/lymphoma: a single-center, retrospective study","volume":"72","author":"Marchetti","year":"2015","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.path.2023.01.009_bib114","doi-asserted-by":"crossref","first-page":"282","DOI":"10.5858\/arpa.2012-0379-RS","article-title":"Adult T-cell leukemia\/lymphoma","volume":"138","author":"Qayyum","year":"2014","journal-title":"Arch Pathol Lab Med"},{"issue":"12","key":"10.1016\/j.path.2023.01.009_bib115","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1346-8138.2009.00722.x","article-title":"Adult T-cell leukemia\/lymphoma associated with follicular mucinosis","volume":"36","author":"Wada","year":"2009","journal-title":"J\u00a0Dermatol"},{"issue":"9","key":"10.1016\/j.path.2023.01.009_bib116","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1097\/PAS.0b013e31828f2322","article-title":"Loss of Foxp3 is associated with CD30 expression in the anaplastic large cell subtype of adult T-cell leukemia\/lymphoma (ATLL) in US\/Caribbean patients: potential therapeutic implications for CD30 antibody-mediated therapy","volume":"37","author":"Yao","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.path.2023.01.009_bib117","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/ijc.20007","article-title":"Genetic and epigenetic inactivation of tax gene in adult T-cell leukemia cells","volume":"109","author":"Takeda","year":"2004","journal-title":"Inr J Cancer"},{"key":"10.1016\/j.path.2023.01.009_bib118","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1073\/pnas.0507631103","article-title":"HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells","volume":"103","author":"Satou","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10.1016\/j.path.2023.01.009_bib119","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1128\/JVI.03025-13","article-title":"Human T-cell leukemia virus type I Tax-deregulated autophagy pathway and c-FLIP expression contribute to resistance against death receptor-mediated apoptosis","volume":"88","author":"Wang","year":"2014","journal-title":"J\u00a0Virol"},{"issue":"2","key":"10.1016\/j.path.2023.01.009_bib120","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/s41379-020-00654-0","article-title":"Human T-cell lymphotropic virus HBZ and tax mRNA expression are associated with specific clinicopathological features in adult T-cell leukemia\/lymphoma","volume":"34","author":"Yamada","year":"2021","journal-title":"Mod Pathol"},{"issue":"11","key":"10.1016\/j.path.2023.01.009_bib121","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/ng.3415","article-title":"Integrated molecular analysis of adult T cell leukemia\/lymphoma","volume":"47","author":"Kataoka","year":"2015","journal-title":"Nat Genet"},{"issue":"11","key":"10.1016\/j.path.2023.01.009_bib122","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1038\/ng.3428","article-title":"The genomic landscape of adult T cell leukemia\/lymphoma","volume":"47","author":"Vicente","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.path.2023.01.009_bib123","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1182\/blood-2017-01-761874","article-title":"Prognostic relevance of integrated genetic profiling in adult T-cell leukemia\/lymphoma","volume":"131","author":"Kataoka","year":"2018","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.path.2023.01.009_bib124","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1111\/j.1365-4632.2011.04882.x","article-title":"Human T-lymphotropic virus 1 (HTLV-1) infection: dermatological implications","volume":"50","author":"Amano","year":"2011","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.path.2023.01.009_bib125","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.annder.2018.01.049","article-title":"Cutaneous presentation of adult T-cell leukemia\/lymphoma (ATLL). Single-center study on 37 patients in metropolitan France between 1996 and 2016","volume":"145","author":"Hurabielle","year":"2018","journal-title":"Ann Dermatol Venereol"},{"issue":"12","key":"10.1016\/j.path.2023.01.009_bib126","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/j.1346-8138.1999.tb02093.x","article-title":"Clinicopathologic analysis of 124 cases of adult T-cell leukemia\/lymphoma with cutaneous manifestations: the smouldering type with skin manifestations has a poorer prognosis than previously thought","volume":"26","author":"Setoyama","year":"1999","journal-title":"J\u00a0Dermatol"},{"issue":"15","key":"10.1016\/j.path.2023.01.009_bib127","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1182\/blood-2010-11-316794","article-title":"Type of skin eruption is an independent prognostic indicator for adult T-cell leukemia\/lymphoma","volume":"117","author":"Sawada","year":"2011","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.path.2023.01.009_bib128","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1365-2133.2004.06274.x","article-title":"Clinicopathological features of cutaneous lesions of adult T-cell leukaemia\/lymphoma","volume":"152","author":"Yamaguchi","year":"2005","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.path.2023.01.009_bib129","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.3892\/ijo.2014.2524","article-title":"Microarray analysis of gene expression by microdissected epidermis and dermis in mycosis fungoides and adult T-cell leukemia\/lymphoma","volume":"45","author":"Hashikawa","year":"2014","journal-title":"Int J Oncol"},{"issue":"19","key":"10.1016\/j.path.2023.01.009_bib130","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1182\/blood-2013-11-536359","article-title":"Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project. Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma","volume":"123","author":"Iqbal","year":"2014","journal-title":"Blood"}],"container-title":["Surgical Pathology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918123000090?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918123000090?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T14:43:13Z","timestamp":1761748993000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875918123000090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":130,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S1875918123000090"],"URL":"https:\/\/doi.org\/10.1016\/j.path.2023.01.009","relation":{},"ISSN":["1875-9181"],"issn-type":[{"value":"1875-9181","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aggressive Cutaneous Lymphomas and Their Mimics","name":"articletitle","label":"Article Title"},{"value":"Surgical Pathology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.path.2023.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}